| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-04-28 10:57:58 UTC |
|---|
| Updated at | 2022-04-28 10:57:58 UTC |
|---|
| NP-MRD ID | NP0066714 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | (-)-Vincawajine |
|---|
| Description | [(1R,10S,12S,13S,14S,16S,17S,18R)-18-(acetyloxy)-4-methoxy-14-methyl-8,15-diazahexacyclo[14.2.1.0¹,⁹.0²,⁷.0¹⁰,¹⁵.0¹²,¹⁷]Nonadeca-2(7),3,5,8-tetraen-13-yl]methyl acetate belongs to the class of organic compounds known as ajmaline-sarpagine alkaloids. These are organic compounds containing either of the ajmalan, sarpagan skeleton, or derivative thereof. The Sarpagine (Akuammidine) group, based on the sarpagan nucleus, arises from bond formation between C-16 and C-5 of the corynantheine precursor. Ajmaline alkaloids are based on a 17,19-secoyohimban skeleton (oxayohimban) which is invariably present as an ether. (-)-Vincawajine is found in Vinca major . Based on a literature review very few articles have been published on [(1R,10S,12S,13S,14S,16S,17S,18R)-18-(acetyloxy)-4-methoxy-14-methyl-8,15-diazahexacyclo[14.2.1.0¹,⁹.0²,⁷.0¹⁰,¹⁵.0¹²,¹⁷]Nonadeca-2(7),3,5,8-tetraen-13-yl]methyl acetate. |
|---|
| Structure | COC1=CC=C2N=C3[C@@H]4C[C@@H]5[C@H]6[C@H](C[C@@]3([C@@H]6OC(C)=O)C2=C1)N4[C@@H](C)[C@H]5COC(C)=O InChI=1S/C24H28N2O5/c1-11-16(10-30-12(2)27)15-8-19-22-24(17-7-14(29-4)5-6-18(17)25-22)9-20(26(11)19)21(15)23(24)31-13(3)28/h5-7,11,15-16,19-21,23H,8-10H2,1-4H3/t11-,15-,16+,19-,20-,21-,23+,24+/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| [(1R,10S,12S,13S,14S,16S,17S,18R)-18-(Acetyloxy)-4-methoxy-14-methyl-8,15-diazahexacyclo[14.2.1.0,.0,.0,.0,]nonadeca-2(7),3,5,8-tetraen-13-yl]methyl acetic acid | Generator |
|
|---|
| Chemical Formula | C24H28N2O5 |
|---|
| Average Mass | 424.4970 Da |
|---|
| Monoisotopic Mass | 424.19982 Da |
|---|
| IUPAC Name | [(1R,10S,12S,13S,14S,16S,17S,18R)-18-(acetyloxy)-4-methoxy-14-methyl-8,15-diazahexacyclo[14.2.1.0^{1,9}.0^{2,7}.0^{10,15}.0^{12,17}]nonadeca-2,4,6,8-tetraen-13-yl]methyl acetate |
|---|
| Traditional Name | [(1R,10S,12S,13S,14S,16S,17S,18R)-18-(acetyloxy)-4-methoxy-14-methyl-8,15-diazahexacyclo[14.2.1.0^{1,9}.0^{2,7}.0^{10,15}.0^{12,17}]nonadeca-2,4,6,8-tetraen-13-yl]methyl acetate |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | COC1=CC=C2N=C3[C@@H]4C[C@@H]5[C@H]6[C@H](C[C@@]3([C@@H]6OC(C)=O)C2=C1)N4[C@@H](C)[C@H]5COC(C)=O |
|---|
| InChI Identifier | InChI=1S/C24H28N2O5/c1-11-16(10-30-12(2)27)15-8-19-22-24(17-7-14(29-4)5-6-18(17)25-22)9-20(26(11)19)21(15)23(24)31-13(3)28/h5-7,11,15-16,19-21,23H,8-10H2,1-4H3/t11-,15-,16+,19-,20-,21-,23+,24+/m0/s1 |
|---|
| InChI Key | NVBKJHMKBGTOJC-LYQRILJPSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as ajmaline-sarpagine alkaloids. These are organic compounds containing either of the ajmalan, sarpagan skeleton, or derivative thereof. The Sarpagine (Akuammidine) group, based on the sarpagan nucleus, arises from bond formation between C-16 and C-5 of the corynantheine precursor. Ajmaline alkaloids are based on a 17,19-secoyohimban skeleton (oxayohimban) which is invariably present as an ether. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Alkaloids and derivatives |
|---|
| Class | Ajmaline-sarpagine alkaloids |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Ajmaline-sarpagine alkaloids |
|---|
| Alternative Parents | |
|---|
| Substituents | - Sarpagine-skeleton
- 3-alkylindole
- Quinolizidine
- Indole or derivatives
- Quinuclidine
- Anisole
- Aralkylamine
- Azepane
- Alkyl aryl ether
- Benzenoid
- Piperidine
- Dicarboxylic acid or derivatives
- Tertiary aliphatic amine
- Tertiary amine
- Ketimine
- Carboxylic acid ester
- Amino acid or derivatives
- Azacycle
- Organoheterocyclic compound
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Ether
- Carboxylic acid derivative
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Imine
- Carbonyl group
- Amine
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|